DrugPatentWatch Database Preview

CEFOTAXIME Drug Profile

« Back to Dashboard

When do Cefotaxime patents expire, and what generic alternatives are available?

Cefotaxime is a drug marketed by Fresenius Kabi Usa, Hikma, Wockhardt, B Braun, Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira Inc, and Lupin. and is included in fourteen NDAs.

The generic ingredient in CEFOTAXIME is cefotaxime sodium. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotaxime sodium profile page.

Summary for CEFOTAXIME

US Patents:	0
Applicants:	9
NDAs:	14
Suppliers / Packagers:	2
Bulk Api Vendors:	78
Clinical Trials:	24
Patent Applications:	815
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	CEFOTAXIME at DailyMed

Pharmacology for CEFOTAXIME

Ingredient-type	Cephalosporins
Drug Class	Cephalosporin Antibacterial

Medical Subject Heading (MeSH) Categories for CEFOTAXIME

Anti-Bacterial Agents

Synonyms for CEFOTAXIME

(+)-Cefotaxime sodium salt

(6R-(6-a,7-b(Z)))-3-((Acetyloxy) methyl)-7- (((2-amino-4-thiazolyl) (methoxyimio) acetyl) amino)-8- oxo-5-thia-1- azabicyclo (4,2,0) oct-2-ene-2-carboxylic acid, sodium salt

(6R-(6-a,7-b(Z)))-3-((Acetyloxy) methyl)-7-(((2-amino-4-thiazolyl) (methoxyimio) acetyl) amino)-8-oxo-5-thia-1-azabicyclo (4,2,0) oct-2-ene-2-carboxylic acid, sodium salt

(6R,7R,Z)-3-(ACETOXYMETHYL)-7-(2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)-ACETAMIDO)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID SODIUM

(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt

258J72S7TZ

3-[(Acetyloxy)methyl]-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amin]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate sodium salt

478250-23-6

5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6-alpha,7-beta(Z))), sodium salt

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(Z)))-

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-(acetyloxy)methyl-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo, monosodium salt, [6R-[6alpha,7 beta (Z)]]-

63527-52-6 (acid)

63527-52-6 (Parent)

64485-93-4

7-[2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO]-3-(HYDROXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE 7(2)-(Z)-(O-METHYLOXIME) ACETATE, NA

A834407

AB0073048

AB03027

AB1009356

AC-23966

AK249539

AK326216

AKOS003274997

AKOS015951272

AKOS015961149

AKOS027282526

AKOS027327590

AmbscH-042283

AN-38760

AZZMGZXNTDTSME-JUZDKLSSSA-M

BIC0111

C 7912

C08113

C16H16N5NaO7S2

C16H16N5O7S2.Na

CAS-64485-93-4

CCG-220139

CCG-221582

CCG-38937

Cefadroxil, Antibiotic for Culture Media Use Only

CEFOPERAZONE SODIUM SALT U.S.P.

Cefotax

Cefotaxim sodium

Cefotaxim sodium salt

Cefotaxime (sodium salt)

Cefotaxime and dextrose 2.4% in plastic container

Cefotaxime and dextrose 3.9% in plastic container

Cefotaxime for peak identification, European Pharmacopoeia (EP) Reference Standard

CEFOTAXIME NA-SALT

CEFOTAXIME SODIUM

Cefotaxime sodium (JP17/USP)

Cefotaxime sodium [USAN:JAN]

Cefotaxime sodium [USAN:USP:JAN]

CEFOTAXIME SODIUM SALT

Cefotaxime sodium salt (syn-isomer)

Cefotaxime sodium salt, plant cell culture tested, BioReagent, powder

Cefotaxime sodium salt, potency: 916-964 mug per mg

Cefotaxime sodium, European Pharmacopoeia (EP) Reference Standard

Cefotaxime sodium, United States Pharmacopeia (USP) Reference Standard

Cefotaximesodium

CHEBI:3498

CHEMBL1010

CHEMBL3561962

Claforan

Claforan (TN)

CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER

CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Claforan sodium

CPD001551784

D00919

DR002957

DSSTox_CID_26991

DSSTox_GSID_46991

DSSTox_RID_82039

DTXSID4046991

EINECS 264-915-9

EN300-122614

EU-0100278

FT-0603036

HE372323

HMS1568K20

HMS1920K09

HMS2091A12

HMS2095K20

HMS2233J21

HMS3259D08

HMS3260H18

HMS3373G07

HMS502G09

HR 756

HR-756

I06-1759

J10142

K035

KS-00004E9I

KS-1416

LP00278

LS-149921

MCULE-9988072641

MFCD00079073

MFCD19705570

MLS000028559

MLS001077352

MLS001333684

MLS002222330

MolPort-003-928-040

MolPort-016-582-515

MolPort-027-714-060

NC00704

NCGC00017128-01

NCGC00093734-01

NCGC00093734-02

NCGC00260963-01

NE54506

Opera_ID_1945

Prestwick_823

Pretor

Q-200807

Ralopar

RU 24756

s4517

SAM002643511

SCHEMBL41092

SCHEMBL537163

SCHEMBL9491367

SMR000058812

SMR000653480

SMR001307269

Sodium (6R-(6alpha,7beta(Z)))-3-(acetoxymethyl)-7-((2-aminothiazol-4-yl)(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate

SODIUM (6R,7R)-3-(ACETOXYMETHYL)-7-((E)-2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE

Sodium (6R,7R)-3-(acetoxymethyl)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

sodium (6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

sodium (6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Sodium (6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7(sup 2)-(Z)-(O-methyloxime), acetate (ester)

Sodium (6R,7R)-7-[2-(2-amino-4-thiazolyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 7[2]-(Z)-(O-methyloxime), acetate (ester)

SODIUM (6S,7S)-3-[(ACETYLOXY)METHYL]-7-[(2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO]-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE

Sodium 3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

sodium 3-(acetoxymethyl)-7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3,4-didehydrocepham-4-carboxylate

sodium 3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

sodium 3-(acetyloxymethyl)-7-[[2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

sodium 3-[(acetyloxy)methyl]-7-[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

sodium 3-[(acetyloxy)methyl]-7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-

Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate

Sodium cefotaxime

sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

SPECTRUM1500165

TL8004572

Tolycar

Tolycor

Tox21_110791

Tox21_500278

UNII-258J72S7TZ

Zariviz

US Patents and Regulatory Information for CEFOTAXIME

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lupin	CEFOTAXIME SODIUM	cefotaxime sodium	INJECTABLE;INJECTION	065124-001	Sep 24, 2003		DISCN	No	No
Wockhardt	CEFOTAXIME SODIUM	cefotaxime sodium	INJECTABLE;INJECTION	065197-003	Jun 20, 2008	AP	RX	No	No
Fresenius Kabi Usa	CEFOTAXIME	cefotaxime sodium	INJECTABLE;INJECTION	064200-002	Mar 24, 2000		DISCN	No	No
Hospira Inc	CEFOTAXIME SODIUM	cefotaxime sodium	INJECTABLE;INJECTION	065290-002	Aug 11, 2006	AP	RX	No	No